相似文献
1
Osteopontin: role in extracellular matrix deposition and myocardial remodeling post-MI.
J Mol Cell Cardiol. 2010 Mar;48(3):538-43. doi: 10.1016/j.yjmcc.2009.06.015. Epub 2009 Jun 30.
2
Exaggerated left ventricular dilation and reduced collagen deposition after myocardial infarction in mice lacking osteopontin.
Circ Res. 2001 May 25;88(10):1080-7. doi: 10.1161/hh1001.090842.
3
Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction.
Mol Cell Biochem. 2009 Feb;322(1-2):53-62. doi: 10.1007/s11010-008-9939-6. Epub 2008 Nov 1.
4
Role of osteopontin in heart failure associated with aging.
Heart Fail Rev. 2010 Sep;15(5):487-94. doi: 10.1007/s10741-010-9158-6.
5
Impairment of myocardial angiogenic response in the absence of osteopontin.
Microcirculation. 2007 Apr-May;14(3):233-40. doi: 10.1080/10739680601139369.
6
MMP induction and inhibition in myocardial infarction.
Heart Fail Rev. 2004 Jan;9(1):7-19. doi: 10.1023/B:HREV.0000011390.44039.b7.
7
IL (Interleukin)-10-STAT3-Galectin-3 Axis Is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction.
Circulation. 2018 Oct 30;138(18):2021-2035. doi: 10.1161/CIRCULATIONAHA.118.035047.
8
TIMP2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation.
Circ Res. 2010 Mar 5;106(4):796-808. doi: 10.1161/CIRCRESAHA.109.209189. Epub 2010 Jan 7.
9
A Novel Collagen Matricryptin Reduces Left Ventricular Dilation Post-Myocardial Infarction by Promoting Scar Formation and Angiogenesis.
J Am Coll Cardiol. 2015 Sep 22;66(12):1364-74. doi: 10.1016/j.jacc.2015.07.035.
10
Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion.
JACC Cardiovasc Imaging. 2012 Sep;5(9):884-93. doi: 10.1016/j.jcmg.2012.03.015.
引用本文的文献
1
Development of an SPRi Immune Method for the Quantitative Detection of Osteopontin.
Sensors (Basel). 2025 Jun 9;25(12):3628. doi: 10.3390/s25123628.
2
Multiple Biomarkers to Predict Major Adverse Cardiovascular Events in Patients With Coronary Chronic Total Occlusions.
Am J Cardiol. 2025 May 1;242:25-31. doi: 10.1016/j.amjcard.2024.12.037. Epub 2025 Jan 6.
3
The pivotal role of osteopontin in UV-induced skin inflammation in a mouse model.
Open Biol. 2024 Nov;14(11):230397. doi: 10.1098/rsob.230397. Epub 2024 Nov 13.
4
Temporal trajectory and left ventricular ejection fraction association of eight circulating biomarkers in first acute myocardial infarction patients: a 12-month prospective cohort study.
Eur Heart J Open. 2024 Oct 15;4(5):oeae090. doi: 10.1093/ehjopen/oeae090. eCollection 2024 Sep.
5
Prognostic Value of Circulating Fibrosis Biomarkers in Dilated Cardiomyopathy (DCM): Insights into Clinical Outcomes.
Biomolecules. 2024 Sep 9;14(9):1137. doi: 10.3390/biom14091137.
6
Expression of Osteopontin and Gremlin 1 Proteins in Cardiomyocytes in Ischemic Heart Failure.
Int J Mol Sci. 2024 Jul 28;25(15):8240. doi: 10.3390/ijms25158240.
7
Dental pulp mesenchymal stem cells-response to fibrin hydrogel reveals ITGA2 and MMPs expression.
Heliyon. 2024 Jun 18;10(13):e32891. doi: 10.1016/j.heliyon.2024.e32891. eCollection 2024 Jul 15.
8
Integrative bioinformatics approach for identifying key genes and potential therapeutic targets in the concurrent manifestation of hypertrophic cardiomyopathy and pulmonary hypertension.
J Thorac Dis. 2024 May 31;16(5):3152-3169. doi: 10.21037/jtd-23-1822. Epub 2024 May 28.
9
The Senescent Heart-"Age Doth Wither Its Infinite Variety".
Int J Mol Sci. 2024 Mar 22;25(7):3581. doi: 10.3390/ijms25073581.
10
Protective effects of macrophage-specific integrin α5 in myocardial infarction are associated with accentuated angiogenesis.
Nat Commun. 2023 Nov 20;14(1):7555. doi: 10.1038/s41467-023-43369-x.
本文引用的文献
1
Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host.
Circ Res. 2009 Apr 10;104(7):851-9. doi: 10.1161/CIRCRESAHA.109.193805. Epub 2009 Feb 26.
2
Blockades of angiotensin and aldosterone reduce osteopontin expression and interstitial fibrosis infiltration in rats with myocardial infarction.
Chin Med J (Engl). 2008 Nov 5;121(21):2192-6.
3
Inhibition of matrix metalloproteinases improves left ventricular function in mice lacking osteopontin after myocardial infarction.
Mol Cell Biochem. 2009 Feb;322(1-2):53-62. doi: 10.1007/s11010-008-9939-6. Epub 2008 Nov 1.
4
Osteopontin: role in immune regulation and stress responses.
Cytokine Growth Factor Rev. 2008 Oct-Dec;19(5-6):333-45. doi: 10.1016/j.cytogfr.2008.08.001. Epub 2008 Oct 25.
5
Matricellular proteins at the crossroad of inflammation and cancer.
Cancer Lett. 2008 Aug 28;267(2):245-53. doi: 10.1016/j.canlet.2008.03.027. Epub 2008 May 8.
6
Inhibiting metalloproteases with PD 166793 in heart failure: impact on cardiac remodeling and beyond.
Cardiovasc Ther. 2008 Spring;26(1):24-37. doi: 10.1111/j.1527-3466.2007.00034.x.
7
Novel role for osteopontin in cardiac fibrosis.
Circ Res. 2008 Feb 15;102(3):270-2. doi: 10.1161/CIRCRESAHA.107.170555.
8
Osteopontin expression is required for myofibroblast differentiation.
Circ Res. 2008 Feb 15;102(3):319-27. doi: 10.1161/CIRCRESAHA.107.160408. Epub 2007 Dec 13.
9
Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function.
Physiol Rev. 2007 Oct;87(4):1285-342. doi: 10.1152/physrev.00012.2007.
10
Control of osteopontin signaling and function by post-translational phosphorylation and protein folding.
J Cell Biochem. 2007 Nov 1;102(4):912-24. doi: 10.1002/jcb.21558.
Zotero 插件